Abstract Submission Information

Abstract Submission Information

Call for Posters Reopened

The conference committee has reopened the call for Posters and will be accepting new submissions until August 30, 2025. For more details please see the Poster Presentations section under Types of Abstracts, below. We look forward to receiving your submission.

Submission Deadline: Saturday, August 30, 2025 at 11:59pm EST.

We are excited to present the CSAM-SMCA 2025 Annual Scientific Conference: Reconsidering Perspectives. We aspire to bring together all who are involved in substance use and addiction care: researchers, clinicians, individuals with lived or living expertise, and allied health care workers. This conference will offer the opportunity to share your work and wisdom with colleagues from across Canada and around the world.

Our theme for 2025 is Reconsidering Perspectives; we are aiming for the conference to be about challenging beliefs, to encourage people to listen with an open mind, and to allow themselves to consider perspectives that may be different than the ones they held prior to attending the conference. We firmly believe that curiosity is the way to heal divisions within our community, and we hope that CSAM-SMCAโ€™s scientific conference will promote a spirit of inquiry that will help us make progress toward shared goals.

Here are some abstract themes that we would be interested in receiving:

  • New research in the understanding or treatment (pharmacological and/or psychological) of substance use disorders and behavioural addictions.
  • All substance-use disorders and behavioural addictions including opioids, alcohol, tobacco, cannabis, stimulants, gambling, and gaming.
  • Policy-relevant innovations in substance use care in the context of the toxic drug supply, including harm reduction approaches
  • Workshops that will help attendees learn a specific psychotherapy modality or skill, that focus on healthcare practitioner wellness and resilience, or skills in advocacy;
  • Abstracts particularly focused on under-represented groups, populations experiencing marginalization, and the social determinants of health.
  • Work and research related to gender issues (i.e. transgender care, womenโ€™s health, perinatal care) in substance use care
  • Clinical pearls, novel care models, new perspectives on old issues, clinical case reports: let your minds go free and share with us!

We encourage community workers, people with lived or living expertise, trainees and early-career researchers to submit their work. Bursaries will be available for some individuals to offset the cost of attending CSAM-SMCA 2025.

The conference will be held in person in Montreal, Quebec, October 16-18, 2025. A selection of the presentations may be recorded live and made available for on-demand viewing following the in-person event to make our conference accessible to as many people as possible.

Submission Deadline is Sunday, April 6, 2025.

Please review the abstract types carefully, to determine what type of presentation best fits the information you want to share. Abstracts must be original work and use evidence-based information rather than anecdotes. Author presentations are expected to align with what is submitted in the proposed abstract. Authors are required to present in person in Montreal and must pay the registration fee. Some presentations may be video recorded for on-demand viewing after the live event.

Symposium

A symposium is a 60 or 90 minute session designed to give conference attendees an in-depth understanding of a specific clinical or scientific topic. Symposia are organized by small groups and should include between three and six related presentations by members of the group. A complete submission needs to include a โ€œSymposium Overview,โ€ abstract and a separate abstract for EACH presentation in the symposium. List the title of the Symposium Overview for EACH abstract submitted as part of the symposium. A symposium must allocate 25 percent of the session time to questions and answers, as required in CME guidelines. Symposia will be presented in person in Montreal, and may be recorded for on-demand viewing at a later date.

Workshop

A workshop is a 45, 60 or 90 minute session intended to give attendees new skills and understanding. Workshop presenters are encouraged to use interactive and experiential teaching formats such as small group discussions, case examples, demonstrations, interactive polls and other skill-building exercises. The plan for the workshop should be described in the abstract. The number of participants in each workshop will be limited to facilitate skill-building and active participation by attendees. Workshops will not be video recorded. Lectures submitted as workshops will be declined.

Oral Presentation

Oral presentations are concise presentations about a research project, new clinical program, educational initiative or other project in addiction medicine and substance use care. Lead authors will have 10-15 minutes to describe their project accompanied by visual aids (slides), followed by five minutes of questions. Abstracts will be grouped together and delivered in moderated Oral Presentation Sessions. These will be in-person presentations, delivered live during the conference and may be recorded for the on-demand conference materials. Submissions from trainees are encouraged. Please note that a project or report may only be submitted for one type of presentation.

Poster Presentation

A Poster presentation is a visual summary of a research project, new clinical program, educational initiative, or other project or proposal in the field of addiction medicine. Submissions from trainees are encouraged. Posters are to be presented in person. Lead Authors will prepare a printed poster to be mounted and displayed during the poster session, describing the project (we suggest organizing the poster with Introduction, Methods, Results and Conclusions, although other written formats are acceptable). Lead authors are expected to attend the poster session in person to discuss their work with conference attendees. Bulletin board space will be provided for each poster along with mounting materials. Lead Authors of Poster Presentations may ALSO share their poster in the conference app by uploading the poster in digital form to their profile. Posters by trainees will be evaluated, with an award for the Best Poster by a Trainee. Please note that a project or report may only be submitted for one type of presentation.

TED-Style Talk

A TED-Style Talk is an opportunity to present a great, well-formed idea in under 18 minutes, followed by five minutes of questions. TED-Style talks are focused on the power of ideas to change lives and, ultimately, the world. These talks are generally delivered without notes, although presenters may use some basic outline notes on cards or a computer during their presentation. These are NOT spontaneous presentations, they are scripted and carefully rehearsed! PowerPoint slides are limited to only absolutely essential illustrations, traditional slides that summarize content are not allowed. TED-Style talks focus on you and your presentationโ€“the slides only complement your ideas, they do not repeat your words.ย 

  • TED-Style talks are personal. The only reason to give a TED talk is that you feel passionately about something, and your sense of purpose creates an energy boost for both you and your audience.ย ย 
  • TED-Style talks often take us on a journey. As the speaker shares their transition from ignorance to understanding of some important truth, we follow along in their footsteps.
  • TED-Style talks are concise. With only 18 minutes, speakers need to cut out any extraneous ideas so that every word counts.

The abstract for a TED-Style talk should be a SUMMARY of your presentation, not a description of what you plan to talk about. TED-Style talks may be recorded live at the conference for the on-demand event.

Other

Do you have a concept for a presentation that ventures beyond conventional categories? These ideas might take the form of a panel discussion, debate, clinical case report, captivating storytelling session, lecture, or any other creative approach to knowledge translation. We are reserving a select few slots, spanning 45-60 minutes, for such “other” presentations. Abstracts submitted under the “other” category will not be considered for other types of presentations.ย  ย  ย ย 

Invited Presentation

Please select this presentation type ONLY if you have been invited to give a presentation at the CSAM-SMCA conference.

  • Please use non-stigmatizing language, generic pharmaceutical names, and a minimum of abbreviations.
  • All abstract submissions should be a maximum of 300 words.
  • Oral or poster presentation abstracts describing a research study must be structured with the following headings:
    Introduction/Background: Briefly describe the context or background of the study, including the research question or problem being addressed.
    Methods: Explain the methodology used, including study design, data collection, and analysis methods.
    Results: Highlight the key findings or outcomes of your work.
    Conclusion: Summarize the implications of the results, and if applicable, suggest potential future research or recommendations.
  • Abstracts can be submitted in English or French. Abstracts must present material in a clear manner with grammar and spelling of a quality suitable for publication. Presentations will be in the language of the abstract.
  • Abstracts and presentations must be free of commercial bias and cannot be used to advertise or advocate for a specific commercial interest.
  • Each abstract submission must include two clear learning objectives. These objectives should outline the key takeaways for participants and reflect the content and purpose of the research or presentation. Please make sure that the learning objectives are formatted correctly. For guidance, please refer to this link.
  • Lead Authors must agree to follow the CSAM-SMCA guidelines for abstracts before submitting an abstract.
  • A signed Conflict of Interest form for EVERY author must be uploaded with the abstract submission. Abstracts without the disclosure statements will be declined.
  • Disclosure Slide: a disclosure slide is required for each oral presentation. Having a financial disclosure will NOT preclude the acceptance of an abstract.
  • After submitting an abstract, the Lead Author will receive a confirmation email. If you do not receive the confirmation email within 24 hours, please contact .
  • Publication: Select conference abstracts may be published in the Canadian Journal of Addiction.
  • CSAM-SMCA has permission to use the abstracts submitted, accepted and the presentations of these abstracts for educational and marketing purposes by the CSAM-SMCA.
  • Abstracts included in the conference proceedings will be available through the conference app.
  • Abstracts accepted for in-person presentation MUST be delivered in person.
  • Presentations that are recorded during the conference will be uploaded to the app when available for on-demand viewing. CSAM-SMCA has permission to use these videos for educational and marketing purposes by CSAM-SMCA.
  • Please do not submit an abstract if you are not confident that you will be able to give the presentation. Cancellations impose a serious burden on the development of the conference program and may negatively impact the overall quality of the program. If extenuating circumstances prevent the attendance of a presenter, please notify as soon as possible so the presentation can be removed from the program.
  • Abstracts will be evaluated by members of the Scientific Conference Committee. Decisions of the Scientific Conference Committee are final.
  • Decisions regarding abstracts will be completed by April 30, 2025.
  • Abstracts that are accepted:
    • Acceptance emails will be sent by May 16, 2025 to the Lead Author.
    • Once the Lead Author has accepted to present, they will receive an email with the date and time of their presentation by June 30, 2025.
    • All presenters must register for the conference and pay the registration fee before their presentation is finalized in the program.
  • Abstracts that are not accepted:
    • The Lead Author will receive an email.
    • Decisions of the Conference Committee are final.
  • Correspondence will only be with the Lead Author, who must notify any co-authors. The Scientific Conference Committee is not responsible for notification emails not received due to incorrect contact information.

We look forward to receiving your submission!